Report Detail
Global Extracellular Vesicle Therapy Market 2026 by Company, Regions, Type and Application, Forecast to 2032
- RnM4717482 |
- 29 June, 2026 |
- Global |
- 120 Pages |
- GIR |
- Other
According to our (Global Info Research) latest study, the global Extracellular Vesicle Therapy market size was valued at US$ 1016 million in 2025 and is forecast to a readjusted size of US$ 1988 million by 2032 with a CAGR of 10.2% during review period.
Extracellular Vesicle Therapy refers to an emerging therapy that uses extracellular vesicles as a therapeutic approach. These extracellular vesicles are small vesicles released by cells that can carry a variety of biological molecules (such as proteins, lipids, and RNA) to transmit signals and exchange substances between cells.
This report is a detailed and comprehensive analysis for global Extracellular Vesicle Therapy market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Extracellular Vesicle Therapy market size and forecasts, in consumption value ($ Million), 2021-2032
Global Extracellular Vesicle Therapy market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Extracellular Vesicle Therapy market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Extracellular Vesicle Therapy market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Extracellular Vesicle Therapy
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Extracellular Vesicle Therapy market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include FUJIFILM Diosynth Biotechnologies, EV Therapeutics, Cellular Biomedicine Group, Codiak BioSciences, Coya Therapeutics, Curexsys, Evox Therapeutics, ExoCoBio, ILIAS Biologics, Rion, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Extracellular Vesicle Therapy market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Exosome-based
Microvesicle-based
Market segment by Application
Cancer Treatment
Regenerative Medicine
Drug Delivery
Other
Market segment by players, this report covers
FUJIFILM Diosynth Biotechnologies
EV Therapeutics
Cellular Biomedicine Group
Codiak BioSciences
Coya Therapeutics
Curexsys
Evox Therapeutics
ExoCoBio
ILIAS Biologics
Rion
SHIFTBIO
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Extracellular Vesicle Therapy product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Extracellular Vesicle Therapy, with revenue, gross margin, and global market share of Extracellular Vesicle Therapy from 2021 to 2026.
Chapter 3, the Extracellular Vesicle Therapy competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Extracellular Vesicle Therapy market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Extracellular Vesicle Therapy.
Chapter 13, to describe Extracellular Vesicle Therapy research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Classification of Extracellular Vesicle Therapy by Type
- 1.3.1 Overview: Global Extracellular Vesicle Therapy Market Size by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Global Extracellular Vesicle Therapy Consumption Value Market Share by Type in 2025
- 1.3.3 Exosome-based
- 1.3.4 Microvesicle-based
- 1.4 Global Extracellular Vesicle Therapy Market by Application
- 1.4.1 Overview: Global Extracellular Vesicle Therapy Market Size by Application: 2021 Versus 2025 Versus 2032
- 1.4.2 Cancer Treatment
- 1.4.3 Regenerative Medicine
- 1.4.4 Drug Delivery
- 1.4.5 Other
- 1.5 Global Extracellular Vesicle Therapy Market Size & Forecast
- 1.6 Global Extracellular Vesicle Therapy Market Size and Forecast by Region
- 1.6.1 Global Extracellular Vesicle Therapy Market Size by Region: 2021 VS 2025 VS 2032
- 1.6.2 Global Extracellular Vesicle Therapy Market Size by Region, (2021-2032)
- 1.6.3 North America Extracellular Vesicle Therapy Market Size and Prospect (2021-2032)
- 1.6.4 Europe Extracellular Vesicle Therapy Market Size and Prospect (2021-2032)
- 1.6.5 Asia-Pacific Extracellular Vesicle Therapy Market Size and Prospect (2021-2032)
- 1.6.6 South America Extracellular Vesicle Therapy Market Size and Prospect (2021-2032)
- 1.6.7 Middle East & Africa Extracellular Vesicle Therapy Market Size and Prospect (2021-2032)
2 Company Profiles
- 2.1 FUJIFILM Diosynth Biotechnologies
- 2.1.1 FUJIFILM Diosynth Biotechnologies Details
- 2.1.2 FUJIFILM Diosynth Biotechnologies Major Business
- 2.1.3 FUJIFILM Diosynth Biotechnologies Extracellular Vesicle Therapy Product and Solutions
- 2.1.4 FUJIFILM Diosynth Biotechnologies Extracellular Vesicle Therapy Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 FUJIFILM Diosynth Biotechnologies Recent Developments and Future Plans
- 2.2 EV Therapeutics
- 2.2.1 EV Therapeutics Details
- 2.2.2 EV Therapeutics Major Business
- 2.2.3 EV Therapeutics Extracellular Vesicle Therapy Product and Solutions
- 2.2.4 EV Therapeutics Extracellular Vesicle Therapy Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 EV Therapeutics Recent Developments and Future Plans
- 2.3 Cellular Biomedicine Group
- 2.3.1 Cellular Biomedicine Group Details
- 2.3.2 Cellular Biomedicine Group Major Business
- 2.3.3 Cellular Biomedicine Group Extracellular Vesicle Therapy Product and Solutions
- 2.3.4 Cellular Biomedicine Group Extracellular Vesicle Therapy Revenue, Gross Margin and Market Share (2021-2026)
- 2.3.5 Cellular Biomedicine Group Recent Developments and Future Plans
- 2.4 Codiak BioSciences
- 2.4.1 Codiak BioSciences Details
- 2.4.2 Codiak BioSciences Major Business
- 2.4.3 Codiak BioSciences Extracellular Vesicle Therapy Product and Solutions
- 2.4.4 Codiak BioSciences Extracellular Vesicle Therapy Revenue, Gross Margin and Market Share (2021-2026)
- 2.4.5 Codiak BioSciences Recent Developments and Future Plans
- 2.5 Coya Therapeutics
- 2.5.1 Coya Therapeutics Details
- 2.5.2 Coya Therapeutics Major Business
- 2.5.3 Coya Therapeutics Extracellular Vesicle Therapy Product and Solutions
- 2.5.4 Coya Therapeutics Extracellular Vesicle Therapy Revenue, Gross Margin and Market Share (2021-2026)
- 2.5.5 Coya Therapeutics Recent Developments and Future Plans
- 2.6 Curexsys
- 2.6.1 Curexsys Details
- 2.6.2 Curexsys Major Business
- 2.6.3 Curexsys Extracellular Vesicle Therapy Product and Solutions
- 2.6.4 Curexsys Extracellular Vesicle Therapy Revenue, Gross Margin and Market Share (2021-2026)
- 2.6.5 Curexsys Recent Developments and Future Plans
- 2.7 Evox Therapeutics
- 2.7.1 Evox Therapeutics Details
- 2.7.2 Evox Therapeutics Major Business
- 2.7.3 Evox Therapeutics Extracellular Vesicle Therapy Product and Solutions
- 2.7.4 Evox Therapeutics Extracellular Vesicle Therapy Revenue, Gross Margin and Market Share (2021-2026)
- 2.7.5 Evox Therapeutics Recent Developments and Future Plans
- 2.8 ExoCoBio
- 2.8.1 ExoCoBio Details
- 2.8.2 ExoCoBio Major Business
- 2.8.3 ExoCoBio Extracellular Vesicle Therapy Product and Solutions
- 2.8.4 ExoCoBio Extracellular Vesicle Therapy Revenue, Gross Margin and Market Share (2021-2026)
- 2.8.5 ExoCoBio Recent Developments and Future Plans
- 2.9 ILIAS Biologics
- 2.9.1 ILIAS Biologics Details
- 2.9.2 ILIAS Biologics Major Business
- 2.9.3 ILIAS Biologics Extracellular Vesicle Therapy Product and Solutions
- 2.9.4 ILIAS Biologics Extracellular Vesicle Therapy Revenue, Gross Margin and Market Share (2021-2026)
- 2.9.5 ILIAS Biologics Recent Developments and Future Plans
- 2.10 Rion
- 2.10.1 Rion Details
- 2.10.2 Rion Major Business
- 2.10.3 Rion Extracellular Vesicle Therapy Product and Solutions
- 2.10.4 Rion Extracellular Vesicle Therapy Revenue, Gross Margin and Market Share (2021-2026)
- 2.10.5 Rion Recent Developments and Future Plans
- 2.11 SHIFTBIO
- 2.11.1 SHIFTBIO Details
- 2.11.2 SHIFTBIO Major Business
- 2.11.3 SHIFTBIO Extracellular Vesicle Therapy Product and Solutions
- 2.11.4 SHIFTBIO Extracellular Vesicle Therapy Revenue, Gross Margin and Market Share (2021-2026)
- 2.11.5 SHIFTBIO Recent Developments and Future Plans
3 Market Competition, by Players
- 3.1 Global Extracellular Vesicle Therapy Revenue and Share by Players (2021-2026)
- 3.2 Market Share Analysis (2025)
- 3.2.1 Market Share of Extracellular Vesicle Therapy by Company Revenue
- 3.2.2 Top 3 Extracellular Vesicle Therapy Players Market Share in 2025
- 3.2.3 Top 6 Extracellular Vesicle Therapy Players Market Share in 2025
- 3.3 Extracellular Vesicle Therapy Market: Overall Company Footprint Analysis
- 3.3.1 Extracellular Vesicle Therapy Market: Region Footprint
- 3.3.2 Extracellular Vesicle Therapy Market: Company Product Type Footprint
- 3.3.3 Extracellular Vesicle Therapy Market: Company Product Application Footprint
- 3.4 New Market Entrants and Barriers to Market Entry
- 3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
- 4.1 Global Extracellular Vesicle Therapy Consumption Value and Market Share by Type (2021-2026)
- 4.2 Global Extracellular Vesicle Therapy Market Forecast by Type (2027-2032)
5 Market Size Segment by Application
- 5.1 Global Extracellular Vesicle Therapy Consumption Value Market Share by Application (2021-2026)
- 5.2 Global Extracellular Vesicle Therapy Market Forecast by Application (2027-2032)
6 North America
- 6.1 North America Extracellular Vesicle Therapy Consumption Value by Type (2021-2032)
- 6.2 North America Extracellular Vesicle Therapy Market Size by Application (2021-2032)
- 6.3 North America Extracellular Vesicle Therapy Market Size by Country
- 6.3.1 North America Extracellular Vesicle Therapy Consumption Value by Country (2021-2032)
- 6.3.2 United States Extracellular Vesicle Therapy Market Size and Forecast (2021-2032)
- 6.3.3 Canada Extracellular Vesicle Therapy Market Size and Forecast (2021-2032)
- 6.3.4 Mexico Extracellular Vesicle Therapy Market Size and Forecast (2021-2032)
7 Europe
- 7.1 Europe Extracellular Vesicle Therapy Consumption Value by Type (2021-2032)
- 7.2 Europe Extracellular Vesicle Therapy Consumption Value by Application (2021-2032)
- 7.3 Europe Extracellular Vesicle Therapy Market Size by Country
- 7.3.1 Europe Extracellular Vesicle Therapy Consumption Value by Country (2021-2032)
- 7.3.2 Germany Extracellular Vesicle Therapy Market Size and Forecast (2021-2032)
- 7.3.3 France Extracellular Vesicle Therapy Market Size and Forecast (2021-2032)
- 7.3.4 United Kingdom Extracellular Vesicle Therapy Market Size and Forecast (2021-2032)
- 7.3.5 Russia Extracellular Vesicle Therapy Market Size and Forecast (2021-2032)
- 7.3.6 Italy Extracellular Vesicle Therapy Market Size and Forecast (2021-2032)
8 Asia-Pacific
- 8.1 Asia-Pacific Extracellular Vesicle Therapy Consumption Value by Type (2021-2032)
- 8.2 Asia-Pacific Extracellular Vesicle Therapy Consumption Value by Application (2021-2032)
- 8.3 Asia-Pacific Extracellular Vesicle Therapy Market Size by Region
- 8.3.1 Asia-Pacific Extracellular Vesicle Therapy Consumption Value by Region (2021-2032)
- 8.3.2 China Extracellular Vesicle Therapy Market Size and Forecast (2021-2032)
- 8.3.3 Japan Extracellular Vesicle Therapy Market Size and Forecast (2021-2032)
- 8.3.4 South Korea Extracellular Vesicle Therapy Market Size and Forecast (2021-2032)
- 8.3.5 India Extracellular Vesicle Therapy Market Size and Forecast (2021-2032)
- 8.3.6 Southeast Asia Extracellular Vesicle Therapy Market Size and Forecast (2021-2032)
- 8.3.7 Australia Extracellular Vesicle Therapy Market Size and Forecast (2021-2032)
9 South America
- 9.1 South America Extracellular Vesicle Therapy Consumption Value by Type (2021-2032)
- 9.2 South America Extracellular Vesicle Therapy Consumption Value by Application (2021-2032)
- 9.3 South America Extracellular Vesicle Therapy Market Size by Country
- 9.3.1 South America Extracellular Vesicle Therapy Consumption Value by Country (2021-2032)
- 9.3.2 Brazil Extracellular Vesicle Therapy Market Size and Forecast (2021-2032)
- 9.3.3 Argentina Extracellular Vesicle Therapy Market Size and Forecast (2021-2032)
10 Middle East & Africa
- 10.1 Middle East & Africa Extracellular Vesicle Therapy Consumption Value by Type (2021-2032)
- 10.2 Middle East & Africa Extracellular Vesicle Therapy Consumption Value by Application (2021-2032)
- 10.3 Middle East & Africa Extracellular Vesicle Therapy Market Size by Country
- 10.3.1 Middle East & Africa Extracellular Vesicle Therapy Consumption Value by Country (2021-2032)
- 10.3.2 Turkey Extracellular Vesicle Therapy Market Size and Forecast (2021-2032)
- 10.3.3 Saudi Arabia Extracellular Vesicle Therapy Market Size and Forecast (2021-2032)
- 10.3.4 UAE Extracellular Vesicle Therapy Market Size and Forecast (2021-2032)
11 Market Dynamics
- 11.1 Extracellular Vesicle Therapy Market Drivers
- 11.2 Extracellular Vesicle Therapy Market Restraints
- 11.3 Extracellular Vesicle Therapy Trends Analysis
- 11.4 Porters Five Forces Analysis
- 11.4.1 Threat of New Entrants
- 11.4.2 Bargaining Power of Suppliers
- 11.4.3 Bargaining Power of Buyers
- 11.4.4 Threat of Substitutes
- 11.4.5 Competitive Rivalry
12 Industry Chain Analysis
- 12.1 Extracellular Vesicle Therapy Industry Chain
- 12.2 Extracellular Vesicle Therapy Upstream Analysis
- 12.3 Extracellular Vesicle Therapy Midstream Analysis
- 12.4 Extracellular Vesicle Therapy Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
- 14.1 Methodology
- 14.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Extracellular Vesicle Therapy. Industry analysis & Market Report on Extracellular Vesicle Therapy is a syndicated market report, published as Global Extracellular Vesicle Therapy Market 2026 by Company, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Extracellular Vesicle Therapy market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
